Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Pharma sector may give...

    Pharma sector may give 25 percent returns in pre-election year: Report

    Written by Ruby Khatun Khatun Published On 2018-09-03T10:00:06+05:30  |  Updated On 3 Sept 2018 10:00 AM IST
    Pharma sector may give 25 percent returns in pre-election year: Report

    New Delhi: The healthcare sector has long been the underperformer but is likely to give as much as 25 percent returns in the pre-election year, while for consumer staples and information technology segment it could be even more, says a report.


    According to Edelweiss Investment Research (EIR), defensive sectors (those stocks that provide a constant dividend and stable earnings regardless of the state of the overall stock market) tend to rally in the year before general election results.


    Some of these defensive sectors include information technology, fast moving consumer goods (FMCG) and healthcare companies.


    "Information technology sector is expected to give 52 percent returns in the pre-election year (12 months prior to the announcement of general election results). For consumer staples and healthcare it would be 29 percent and 25 percent respectively," Joaquim Fernandes Research Analyst at EIR told.


    Since January this year, IT and FMCG have been outperforming the market by a huge margin, while pharma has been an underperformer and hence is likely to see an uptrend in the coming days.


    "Pharma has long been the underperformer and is currently seeing some triggers supporting a trend reversal," Fernandes added.


    According to Edelweiss Investment Research, there is a strong correlation between the S&P US pharma index and NSE Pharma Index and post a four-year consolidation both indices have broken out together and are likely to rise in the coming months.


    Moreover, an equally weighted 10 stocks of NSE Pharma Index indicates that momentum is picking in the pharma pack.


    "NSE Pharma Index has completed a 40 percent decline. Now, we are seeing a breakout from that correction and this gives us confidence that we will see a trend reversal," Fernandes said, adding that dollar strengthening or rupee depreciating will give another tailwind effect on the sector.

    consumer staplesEdelweiss Investment ResearchEIRfast-moving consumer goodsFMCGHealthcare sectorinformation technologyITpharma sectorpre-election yearreturns
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok